株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫測定の世界市場予測 2023年:ELISA、迅速試験、ELISPOT、ウェスタンブロット、イムノPCR

Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 289163
出版日 ページ情報 英文 345 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.05円で換算しております。
Back to Top
免疫測定の世界市場予測 2023年:ELISA、迅速試験、ELISPOT、ウェスタンブロット、イムノPCR Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User - Global Forecast to 2023
出版日: 2018年05月14日 ページ情報: 英文 345 Pages
概要

免疫測定の市場規模は、2018年の201億9,000万米ドルから、2023年までに271億5,000万米ドルへと、6.1%のCAGR (年間複合成長率) で拡大すると予測されています。慢性疾患・感染症の発症率増加、免疫測定装置の技術進歩と新しい自動化システムの投入、およびバイオテクノロジー・バイオ医薬品産業の成長などは、免疫測定市場を促進する主な要因となっています。一方、免疫測定装置・消耗品の認可に対する厳しい規制要件などは、同市場の成長よ抑制する見込みです。

当レポートでは、世界の免疫測定市場について調査し、市場の基本的構造や最新動向、主な市場促進・阻害要因、市場規模の動向見通し、サービス、プラットフォーム、技術、標準標本、用途、エンドユーザーおよび地域別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 免疫測定:市場概要
  • アジア太平洋の免疫測定市場:プラットフォーム別
  • 免疫測定市場:製品・サービス別
  • 免疫測定市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 免疫測定市場:製品・サービス別

  • イントロダクション
  • 試薬 & キット
    • タイプ別
  • アナライザー
    • タイプ別
    • 購入形態別
  • ソフトウェア・サービス

第7章 免疫測定市場:プラットフォーム別

  • イントロダクション
  • 化学ルミネセンス免疫測定
  • 蛍光免疫測定
  • 比色免疫測定 (CI)
  • 放射免疫測定 (RIA)
  • その他のプラットフォーム

第8章 免疫測定市場:技術別

  • イントロダクション
  • 酵素結合免疫吸着測定法 (ELIZA)
  • 迅速試験
  • 酵素結合免疫スポット (ELISPOT)
  • ウェスタンブロット
  • イムノPCR
  • その他の技術

第9章 免疫測定市場:標準標本別

  • イントロダクション
  • 血液
  • 唾液
  • 尿
  • その他の標準標本

第10章 免疫測定市場:用途別

  • イントロダクション
  • 感染症
  • 内分泌学
  • 骨 & ミネラル代謝障害
  • 心血管
  • 血液学・血液スクリーニング
  • 自己免疫疾患
  • 毒物学
  • 新生児スクリーニング
  • その他の用途

第11章 免疫測定市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 臨床検査室
  • 医薬品企業・バイオテクノロジー企業・CRO
  • 血液バンク
  • 研究所・学術研究所
  • その他のエンドユーザー

第12章 世界の免疫測定市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • イタリア
    • フランス
    • スペイン
    • 英国
    • ロシア
    • その他の欧州 (ROE)
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • インドネシア
    • その他のアジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第13章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第14章 企業プロファイル

  • ROCHE
  • ABBOTT LABORATORIES
  • SIEMENS
  • DANAHER
  • DIASORIN
  • SYSMEX
  • BIOMERIEUX
  • ORTHO CLINICAL DIAGNOSTICS
  • QIAGEN
  • THERMO FISHER SCIENTIFIC
  • BECTON, DICKINSON & COMPANY
  • BIO-RAD LABORATORIES
  • AGILENT TECHNOLOGIES
  • MINDRAY
  • PERKINELMER
  • QUIDEL
  • MERCK
  • BIO-TECHNE

第15章 付録

目次
Product Code: MD 4751

"The global immunoassays market is projected to grow at a CAGR of 6.1% during the forecast period."

The immunoassays market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1%. The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, growth in the biotechnology and biopharmaceutical industries, increasing adoption of immunoassay-based point-of-care testing and rapid testing, and the vital role of immunoassays in drug and alcohol testing are the major factors driving the growth of this market. On the other hand, stringent regulatory requirements for the approval of immunoassay instruments and consumables and the implementation of excise duty by the US government are expected to restrain the growth of this market during the forecast period.

"Hospitals to dominate the end-user market during the forecast period."

By end user, the immunoassays market is segmented into hospitals, clinical laboratories, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies and contract research organizations (CROs), and other end users. The hospitals segment is expected to grow at the highest CAGR during the forecast period. Immunoassays are widely used by hospitals and hospitals-attached laboratories for the diagnosis of infectious diseases, which is the key factor driving the growth of this end-user segment.

"Asia Pacific is estimated to grow at the highest CAGR during the study period."

The immunoassays market in the Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in this region can be attributed to the demand for better healthcare services, increasing incidence of chronic and infectious diseases, rapid development in the healthcare infrastructure of developing countries such as India, China, and South Korea, growing healthcare research investments in this region, and increasing per capita income of the middle-class population in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 60%, Tier 2 - 20% and Tier 3 - 20%
  • By Designation - C-level - 40%, Director-level - 20%, Others - 40%
  • By Region - North America - 50%, Europe - 20%, Asia Pacific- 30%

The key players in the immunoassays market include: DiaSorin (Italy), Siemens (Germany), bioMerieux (France), Abbott Laboratories (US), Roche (Switzerland), Sysmex Corporation (Japan), Danaher Corporation (US), Ortho Clinical Diagnostics (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Merck (Germany), Agilent Technologies (US), Quidel Corporation (US), Bio-Techne Corporation (US), PerkinElmer (US), and Mindray (China).

Research Coverage:

The report analyses the immunoassays market by product and service, platform, technology, specimen type, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms to garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the immunoassays market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the immunoassays market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the immunoassays market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various immunoassays across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the immunoassays market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. IMMUNOASSAYS: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PLATFORM (2017)
  • 4.3. IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE (2018-2023)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE IMMUNOASSAYS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing incidence of chronic and infectious diseases
        • 5.2.1.1.1. Increasing use of immunoassays in oncology
        • 5.2.1.1.2. Growing geriatric population
      • 5.2.1.2. Technological advancements in immunoassay instruments and introduction of novel automated systems
      • 5.2.1.3. Growth in the biotechnology and biopharmaceutical industries
      • 5.2.1.4. Increasing adoption of immunoassay-based point-of-care testing and rapid testing
      • 5.2.1.5. Vital role of immunoassays in drug and alcohol testing
        • 5.2.1.5.1. Growing drug and alcohol consumption
        • 5.2.1.5.2. Enforcement of stringent laws mandating drug and alcohol testing
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent regulatory requirements for the approval of immunoassay instruments and consumables
      • 5.2.2.2. Implementation of excise duty on the sale of medical devices in the US
      • 5.2.2.3. Unfavorable reimbursement scenario
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth opportunities in emerging economies
      • 5.2.3.2. Increasing importance of companion diagnostics in the immunoassays market
      • 5.2.3.3. Development of condition-specific biomarkers and tests
      • 5.2.3.4. Integration of microfluidics technology in immunoassays
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Complexities in conducting diagnostic tests

6. IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS & KITS
    • 6.2.1. REAGENTS & KITS MARKET, BY TYPE
      • 6.2.1.1. ELISA reagents & kits
      • 6.2.1.2. Rapid test reagents & kits
      • 6.2.1.3. ELISPOT reagents & kits
      • 6.2.1.4. Western blot reagents & kits
      • 6.2.1.5. Other reagents & kits
  • 6.3. ANALYZERS
    • 6.3.1. IMMUNOASSAY ANALYZERS MARKET, BY TYPE
      • 6.3.1.1. Open-ended systems
      • 6.3.1.2. Closed-ended systems
    • 6.3.2. IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE
      • 6.3.2.1. Rental purchase
      • 6.3.2.2. Outright purchase
  • 6.4. SOFTWARE & SERVICES

7. IMMUNOASSAYS MARKET, BY PLATFORM

  • 7.1. INTRODUCTION
  • 7.2. CHEMILUMINESCENCE IMMUNOASSAYS
  • 7.3. FLUORESCENCE IMMUNOASSAYS
  • 7.4. COLORIMETRIC IMMUNOASSAYS
  • 7.5. RADIOIMMUNOASSAYS
  • 7.6. OTHER PLATFORMS

8. IMMUNOASSAYS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. ENZYME-LINKED IMMUNOSORBENT ASSAYS
    • 8.2.1. ELISA MARKET, BY GENERATION
      • 8.2.1.1. First-generation ELISA
      • 8.2.1.2. Second-generation ELISA
      • 8.2.1.3. Third-generation ELISA
      • 8.2.1.4. Fourth-generation & Above ELISA
  • 8.3. RAPID TESTS
  • 8.4. ENZYME-LINKED IMMUNOSPOT
  • 8.5. WESTERN BLOTTING
  • 8.6. IMMUNO-PCR
  • 8.7. OTHER TECHNOLOGIES

9. IMMUNOASSAYS MARKET, BY SPECIMEN TYPE

  • 9.1. INTRODUCTION
  • 9.2. BLOOD
  • 9.3. SALIVA
  • 9.4. URINE
  • 9.5. OTHER SPECIMENS

10. IMMUNOASSAYS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. INFECTIOUS DISEASES
  • 10.3. ENDOCRINOLOGY
  • 10.4. ONCOLOGY
  • 10.5. BONE & MINERAL DISORDERS
  • 10.6. CARDIOLOGY
  • 10.7. HEMATOLOGY & BLOOD SCREENING
  • 10.8. AUTOIMMUNE DISORDERS
  • 10.9. TOXICOLOGY
  • 10.10. NEONATAL SCREENING
  • 10.11. OTHER APPLICATIONS

11. IMMUNOASSAYS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. HOSPITALS
  • 11.3. CLINICAL LABORATORIES
  • 11.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES & CROS
  • 11.5. BLOOD BANKS
  • 11.6. RESEARCH & ACADEMIC LABORATORIES
  • 11.7. OTHER END USERS

12. GLOBAL IMMUNOASSAYS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. US
    • 12.2.2. CANADA
    • 12.2.3. MEXICO
  • 12.3. EUROPE
    • 12.3.1. GERMANY
    • 12.3.2. ITALY
    • 12.3.3. FRANCE
    • 12.3.4. SPAIN
    • 12.3.5. UK
    • 12.3.6. RUSSIA
    • 12.3.7. REST OF EUROPE
  • 12.4. ASIA PACIFIC
    • 12.4.1. JAPAN
    • 12.4.2. CHINA
    • 12.4.3. INDIA
    • 12.4.4. AUSTRALIA
    • 12.4.5. SOUTH KOREA
    • 12.4.6. INDONESIA
    • 12.4.7. REST OF ASIA PACIFIC
  • 12.5. LATIN AMERICA
  • 12.6. MIDDLE EAST & AFRICA

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS
  • 13.3. COMPETITIVE SITUATION AND TRENDS
    • 13.3.1. PRODUCT LAUNCHES
    • 13.3.2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 13.3.3. EXPANSIONS
    • 13.3.4. ACQUISITIONS

14. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 14.1. ROCHE
  • 14.2. ABBOTT LABORATORIES
  • 14.3. SIEMENS
  • 14.4. DANAHER
  • 14.5. DIASORIN
  • 14.6. SYSMEX
  • 14.7. BIOMERIEUX
  • 14.8. ORTHO CLINICAL DIAGNOSTICS
  • 14.9. QIAGEN
  • 14.10. THERMO FISHER SCIENTIFIC
  • 14.11. BECTON, DICKINSON & COMPANY
  • 14.12. BIO-RAD LABORATORIES
  • 14.13. AGILENT TECHNOLOGIES
  • 14.14. MINDRAY
  • 14.15. PERKINELMER
  • 14.16. QUIDEL
  • 14.17. MERCK
  • 14.18. BIO-TECHNE

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. INDUSTRY INSIGHTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.5. AVAILABLE CUSTOMIZATIONS
  • 15.6. RELATED REPORTS
  • 15.7. AUTHOR DETAILS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 7: IMMUNOASSAYS MARKET, BY PLATFORM, 2018 VS. 2023 (USD BILLION)
  • FIGURE 8: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD BILLION)
  • FIGURE 9: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 10: IMMUNOASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
  • FIGURE 11: IMMUNOASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
  • FIGURE 12: IMMUNOASSAYS MARKET, BY REGION, 2018 VS. 2023 (USD BILLION)
  • FIGURE 13: INCREASING INCIDENCE OF CHRONIC & INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN IMMUNOASSAY INSTRUMENTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: CHEMILUMINESCENCE IMMUNOASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC IMMUNOASSAYS MARKET IN 2017
  • FIGURE 15: SOFTWARE & SERVICES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: CHINA & INDIA TO WITNESS THE HIGHEST GROWTH RATES IN THE IMMUNOASSAYS MARKET FROM 2018 TO 2023
  • FIGURE 17: IMMUNOASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: GLOBAL INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045
  • FIGURE 19: GLOBAL AGING POPULATION, BY REGION, 2017 VS. 2050 (MILLION)
  • FIGURE 20: IMMUNOASSAY REAGENTS & KITS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: ELISA REAGENTS & KITS SEGMENT TO DOMINATE THE IMMUNOASSAY REAGENTS & KITS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: OPEN-ENDED SYSTEMS SEGMENT TO DOMINATE THE IMMUNOASSAY ANALYZERS MARKET, BY TYPE, DURING THE FORECAST PERIOD
  • FIGURE 23: RENTAL PURCHASE SEGMENT TO DOMINATE THE IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, DURING THE FORECAST PERIOD
  • FIGURE 24: CHEMILUMINESCENCE IMMUNOASSAYS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: FOURTH-GENERATION & ABOVE ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: BLOOD SAMPLES SEGMENT TO DOMINATE THE IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, DURING THE FORECAST PERIOD
  • FIGURE 28: INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: NUMBER OF PEOPLE LIVING WITH HIV GLOBALLY, 2010 - 2016
  • FIGURE 30: HOSPITALS SEGMENT TO DOMINATE THE IMMUNOASSAYS MARKET IN 2023
  • FIGURE 31: NORTH AMERICA TO DOMINATE THE GLOBAL IMMUNOASSAYS MARKET IN 2018
  • FIGURE 32: NORTH AMERICA: IMMUNOASSAYS MARKET SNAPSHOT
  • FIGURE 33: ASIA PACIFIC: IMMUNOASSAYS MARKET SNAPSHOT
  • FIGURE 34: MARKET SHARE ANALYSIS - 2017
  • FIGURE 35: ROCHE: COMPANY SNAPSHOT (2017)
  • FIGURE 36: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 37: SIEMENS: COMPANY SNAPSHOT (2017)
  • FIGURE 38: DANAHER: COMPANY SNAPSHOT (2017)
  • FIGURE 39: DIASORIN: COMPANY SNAPSHOT (2016)
  • FIGURE 40: SYSMEX: COMPANY SNAPSHOT (2017)
  • FIGURE 41: BIOMERIEUX: COMPANY SNAPSHOT (2016)
  • FIGURE 42: QIAGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 43: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 44: BD: COMPANY SNAPSHOT (2017)
  • FIGURE 45: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 46: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
  • FIGURE 47: PERKINELMER: COMPANY SNAPSHOT (2017)
  • FIGURE 48: QUIDEL: COMPANY SNAPSHOT (2016)
  • FIGURE 49: MERCK: COMPANY SNAPSHOT (2016)
  • FIGURE 50: BIO-TECHNE: COMPANY SNAPSHOT (2017)

LIST OF TABLES

  • TABLE 1: GLOBAL INCIDENCE OF INFECTIOUS DISEASES IN 2015
  • TABLE 2: GLOBAL INCIDENCE OF THE TOP 10 CANCERS (2012, 2015, & 2035)
  • TABLE 3: DETECTION OF DRUGS BY URINE TESTING
  • TABLE 4: NEW TESTS LAUNCHED BY KEY PLAYERS
  • TABLE 5: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 6: IMMUNOASSAY REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 8: ELISA REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: RAPID TEST REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: ELISPOT REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: WESTERN BLOT REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: OTHER REAGENTS & KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 15: OPEN-ENDED SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: CLOSED-ENDED SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 18: IMMUNOASSAY ANALYZERS RENTAL PURCHASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: IMMUNOASSAY ANALYZERS OUTRIGHT PURCHASE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: IMMUNOASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 22: CLIA SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 23: CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: FLUORESCENCE IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: RADIOIMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: OTHER PLATFORMS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 29: KEY ELISA SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 30: ELISA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 32: FIRST-GENERATION ELISA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: SECOND-GENERATION ELISA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: THIRD-GENERATION ELISA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: FOURTH-GENERATION & ABOVE ELISA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 36: KEY RAPID TESTS AVAILABLE IN THE MARKET
  • TABLE 37: RAPID TESTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 38: ELISPOT MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 40: WESTERN BLOTTING MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 41: IMMUNO-PCR MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 42: OTHER IMMUNOASSAY TECHNOLOGIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 44: IMMUNOASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: IMMUNOASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 46: IMMUNOASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: IMMUNOASSAYS MARKET FOR OTHER SPECIMENS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 48: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 49: IMMUNOASSAYS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: IMMUNOASSAYS MARKET FOR ENDOCRINOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 51: IMMUNOASSAYS MARKET FOR ONCOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: IMMUNOASSAYS MARKET FOR BONE & MINERAL DISORDERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 53: IMMUNOASSAYS MARKET FOR CARDIOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: IMMUNOASSAYS MARKET FOR HEMATOLOGY & BLOOD SCREENING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 55: IMMUNOASSAYS MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: IMMUNOASSAYS MARKET FOR TOXICOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 57: IMMUNOASSAYS MARKET FOR NEONATAL SCREENING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 58: IMMUNOASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 59: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: IMMUNOASSAYS MARKET FOR HOSPITALS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 61: IMMUNOASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 62: IMMUNOASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 63: IMMUNOASSAYS MARKET FOR BLOOD BANKS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 64: IMMUNOASSAYS MARKET FOR RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 65: IMMUNOASSAYS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 66: IMMUNOASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: NORTH AMERICA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 69: NORTH AMERICA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 72: NORTH AMERICA: IMMUNOASSAYS MARKET, BY TECHNOLOGY,2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 74: NORTH AMERICA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 75: NORTH AMERICA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 77: NORTH AMERICA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 78: US: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 79: US: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: US: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: US: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 82: US: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 83: US: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 84: US: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 85: US: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: US: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 87: US: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 88: CANADA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 89: CANADA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: CANADA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: CANADA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 92: CANADA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 93: CANADA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 94: CANADA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 95: CANADA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: CANADA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 97: CANADA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 98: MEXICO: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 99: MEXICO: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: MEXICO: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: MEXICO: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 102: MEXICO: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 103: MEXICO: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 104: MEXICO: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 105: MEXICO: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: MEXICO: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 107: MEXICO: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 108: EUROPE: IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 109: EUROPE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 110: EUROPE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 113: EUROPE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 114: EUROPE: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 115: EUROPE: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 116: EUROPE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: EUROPE: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 118: EUROPE: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 119: GERMANY: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 120: GERMANY: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: GERMANY: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: GERMANY: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 123: GERMANY: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 124: GERMANY: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 125: GERMANY: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 126: GERMANY: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: GERMANY: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 128: GERMANY: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 129: ITALY: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 130: ITALY: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 131: ITALY: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: ITALY: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 133: ITALY: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 134: ITALY: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 135: ITALY: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 136: ITALY: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 137: ITALY: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 138: ITALY: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 139: FRANCE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 140: FRANCE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE,2016-2023 (USD MILLION)
  • TABLE 141: FRANCE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: FRANCE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 143: FRANCE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 144: FRANCE: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 145: FRANCE: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 146: FRANCE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 147: FRANCE: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 148: FRANCE: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 149: SPAIN: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 150: SPAIN: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: SPAIN: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: SPAIN: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 153: SPAIN: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 154: SPAIN: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 155: SPAIN: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 156: SPAIN: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 157: SPAIN: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 158: SPAIN: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 159: UK: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 160: UK: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 161: UK: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: UK: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 163: UK: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 164: UK: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 165: UK: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 166: UK: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 167: UK: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 168: UK: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 169: RUSSIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 170: RUSSIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 171: RUSSIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: RUSSIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 173: RUSSIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 174: RUSSIA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 175: RUSSIA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 176: RUSSIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: RUSSIA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 178: RUSSIA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 179: ROE: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 180: ROE: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE,2016-2023 (USD MILLION)
  • TABLE 181: ROE: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 182: ROE: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 183: ROE: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 184: ROE: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 185: ROE: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 186: ROE: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 187: ROE: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 188: ROE: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 189: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 190: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 191: ASIA PACIFIC: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 192: ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 193: ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 194: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 195: ASIA PACIFIC: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 196: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 197: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 198: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 199: ASIA PACIFIC: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 200: JAPAN: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 201: JAPAN: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: JAPAN: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 203: JAPAN: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE,2016-2023 (USD MILLION)
  • TABLE 204: JAPAN: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 205: JAPAN: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 206: JAPAN: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 207: JAPAN: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: JAPAN: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 209: JAPAN: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 210: CHINA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 211: CHINA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: CHINA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 213: CHINA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 214: CHINA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 215: CHINA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 216: CHINA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 217: CHINA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: CHINA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 219: CHINA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 220: INDIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 221: INDIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE,2016-2023 (USD MILLION)
  • TABLE 222: INDIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 223: INDIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 224: INDIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 225: INDIA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 226: INDIA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 227: INDIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 228: INDIA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 229: INDIA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 230: AUSTRALIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 231: AUSTRALIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 232: AUSTRALIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 233: AUSTRALIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 234: AUSTRALIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 235: AUSTRALIA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 236: AUSTRALIA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 237: AUSTRALIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE,2016-2023 (USD MILLION)
  • TABLE 238: AUSTRALIA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 239: AUSTRALIA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 240: SOUTH KOREA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 241: SOUTH KOREA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE,2016-2023 (USD MILLION)
  • TABLE 242: SOUTH KOREA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 243: SOUTH KOREA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 244: SOUTH KOREA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 245: SOUTH KOREA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 246: SOUTH KOREA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 247: SOUTH KOREA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 248: SOUTH KOREA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 249: SOUTH KOREA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 250: INDONESIA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE,2016-2023 (USD MILLION)
  • TABLE 251: INDONESIA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 252: INDONESIA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE,2016-2023 (USD MILLION)
  • TABLE 253: INDONESIA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 254: INDONESIA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 255: INDONESIA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 256: INDONESIA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 257: INDONESIA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE,2016-2023 (USD MILLION)
  • TABLE 258: INDONESIA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 259: INDONESIA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 260: ROAPAC: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE,2016-2023 (USD MILLION)
  • TABLE 261: ROAPAC: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 262: ROAPAC: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 263: ROAPAC: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 264: ROAPAC: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 265: ROAPAC: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 266: ROAPAC: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 267: ROAPAC: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 268: ROAPAC: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 269: ROAPAC: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 270: LATIN AMERICA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 271: LATIN AMERICA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 272: LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 273: LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE, 2016-2023 (USD MILLION)
  • TABLE 274: LATIN AMERICA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 275: LATIN AMERICA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 276: LATIN AMERICA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 277: LATIN AMERICA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 278: LATIN AMERICA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 279: LATIN AMERICA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 280: MEA: IMMUNOASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 281: MEA: IMMUNOASSAY REAGENTS & KITS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 282: MEA: IMMUNOASSAY ANALYZERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 283: MEA: IMMUNOASSAY ANALYZERS MARKET, BY PURCHASE MODE,2016-2023 (USD MILLION)
  • TABLE 284: MEA: IMMUNOASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 285: MEA: ELISA MARKET, BY GENERATION, 2016-2023 (USD MILLION)
  • TABLE 286: MEA: IMMUNOASSAYS MARKET, BY PLATFORM, 2016-2023 (USD MILLION)
  • TABLE 287: MEA: IMMUNOASSAYS MARKET, BY SPECIMEN TYPE, 2016-2023 (USD MILLION)
  • TABLE 288: MEA: IMMUNOASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 289: MEA: IMMUNOASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 290: PRODUCT LAUNCHES, 2014-2017
  • TABLE 291: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2014-2017
  • TABLE 292: EXPANSIONS, 2014-2017
  • TABLE 293: ACQUISITIONS, 2014-2017
Back to Top